SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centrus shares are drawing attention amid a steep, volatile selloff, with traders blaming share dilution from equity and warrant offerings, a rich valuation, and the cost and execution risks of expanding enrichment capacity. Bulls counter that DOE and commercial fuel contracts support the longer-term domestic nuclear-fuel and HALEU opportunity, while bearish traders question when that growth will translate into results.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to fresh 52-week highs ahead of the Q3 report has traders focused on BRIUMVIs sales momentum and the possibility of stronger guidance. The community also points to heavy call activity and short interest, while debating whether the rally reflects earnings positioning and momentum or unconfirmed buyout speculation; upcoming subcutaneous BRIUMVI data is another catalyst in view.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA accelerated approval of a competing treatment for recurrent respiratory papillomatosis has raised concerns about competition for Precigens PAPZIMEOS and prompted debate over its potential effect on sales. Traders weigh the rivals dosing advantages against PAPZIMEOS commercial head start, established payer access and stronger first-year response data, while also watching Precigens upcoming earnings for evidence of continued uptake.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 78,059.66839082 USD and is up 0.67 over the last 24 hours. It is currently trading on 12773 active market(s) with $13,095,082,899.62 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

A major Binance security breach and the exchanges resumption of withdrawals are driving concern about crypto-market security and potential outflows. Traders are split between fearing further selling or contagion and arguing that Bitcoins relative resilience makes the selloff a buying opportunity.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios post-earnings selloff follows a Q3 beat and higher full-year outlook, as its Q4 organic growth guidance signaled a slowdown from the prior quarter. Traders are divided between viewing the drop as an overreaction with bounce potential and waiting for the stock to stabilize as investors reassess the growth outlook.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

The European Lithium acquisition and resulting CRML share issuance are driving debate, with some traders concerned about dilution and potential selling pressure while others see the added cash and assets, including greater ownership of Tanbreez, as a positive. High-borrow-cost and short-squeeze speculation is also prominent, though traders disagree on whether it will lead to sustained buying.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs large equity raise and stock-funded Elisity acquisition have put dilution and capital allocation at the center of discussion as shares sell off. Some traders see the deal as extending the company into cybersecurity and broader quantum infrastructure, while others question its value per share and want evidence that acquisitions and quantum programs can translate into recurring revenue.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,809.831273 with 281,866,746.118905 in circulation. The last known price of OFFICIAL TRUMP is 1.73532194 USD and is up 9.97 over the last 24 hours. It is currently trading on 744 active market(s) with $259,407,006.57 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

Discussion centers on the TRUMP meme coins steep decline and claims that it was a pump-and-dump that left retail holders with losses. Bearish traders call it a scam and expect further selling, while some holders argue for accumulation or a speculative rebound.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Mercks quarterly results beat expectations and the company raised its full-year outlook, prompting bullish reactions alongside attention to the stocks technical strength. Traders also weigh the positive update against longer-term concerns about Keytrudas patent cliff and pipeline growth.

TRON (TRX) is a cryptocurrency launched in 2018. TRON has a current supply of 95,023,844,090.614844 with 95,023,861,343.880544 in circulation. The last known price of TRON is 0.3125405 USD and is up 1.67 over the last 24 hours. It is currently trading on 1389 active market(s) with $1,085,916,839.31 traded over the last 24 hours. More information can be found at https://trondao.org/.

Tron

TRONs price actionits perceived resilience and gradual moves around key technical levelsis the main focus, alongside its role in stablecoin transfers. Bulls see the consolidation as a base for further gains, while skeptics cite pullbacks, lagging performance, and years of limited movement.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop systemtoday announced CE mark and UKCA approval for its latest Optive AI software update in Europe, further...

These Stocks are Lighting it Up

These names stand out for very different reasons: NeOnc Technologies (NASDAQ:NTHI), Hyperfine (NASDAQ:HYPR), bioAffinity Technologies (NASDAQ:BIAF), Profound Medical (NASDAQ:PROF), Wolfspeed (NYSE: WOLF) and Sunshine Biopharma (NASDAQ:SBFM).

Hyperfine’s Portable MRI Just Hit New Gear with 53% Revenue Surge

Hyperfine (NASDAQ:HYPR) is showing signs that its portable brain-imaging strategy may be moving from an intriguing medical-device concept toward a scalable commercial business.

Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop systemtoday announced preliminary, unaudited revenue, net cash burn, and cash and cash equivalents for the...

Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop systemtoday announced that it will report financial results for the third quarter 2026 on Monday, November...

Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop systemtoday announced the appointment of Roots Pharmaceutical Co. W.L.L. as its exclusive distribution...

Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop System with Contrast Agents

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop systemtoday announced that it has completed enrollment of the Contrast PMR study, a prospective...

Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop systemtoday announced plans to participate in the upcoming Lake Street Capital Markets 10th Annual Best...

Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop systemtoday announced the peer-reviewed publication of the NEURO PMR study in the Journal of Neuroimaging...

Hyperfine Announces FDA Clearance of the Next Optive AI Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop System Across Care Settings

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop systemtoday announced that it has received FDA clearance for its latest Optive AI software update. This...

Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT.

Hyperfine Inc - Ordinary Shares - Class A

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.7176
Prev Close	$0.7436
Open	$0.73
Dividend Yield	0.00%
50-Day Moving Average	$0.8125
Beta	1.54
Avg. Volume	425,027.75
PE Ratio	-1.87

52-Week High	$1.94
52-Week Low	$0.6955
Market Capitalization	$76.1M
EPS (Annual)	-$0.4349
Price to Book	2.07
Revenue Per Employee	$132,970.59

Feed

News

Sentiment

Earnings

Fundamentals

Info

HYPR Fundamentals